Because the in vitro experiments revealed that the c-Met inhibitor PF02341066 effectively suppressed the proliferation and induced apoptosis of MNNG/HOS cells and MNNG/HOS-OSCs, we then investigated whether PF02341066 could reduce tumor growth in vivo. The gene discussed is MET; the disease is neoplasm.